Ignite Creation Date:
2024-05-06 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05991895
Status:
RECRUITING
Last Update Posted:
2023-08-15
First Post:
2023-08-08
Brief Title:
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer
Sponsor:
Jinming Yu
Organization:
Shandong Cancer Hospital and Institute
Organization Data
Organization:
Shandong Cancer Hospital and Institute
Class:
OTHER
Study ID:
IRU-RWS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jinming Yu
Lead Sponsor Class:
OTHER
Responsible Party:
Jinming Yu
Responsible Party Title:
Director of the hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shandong Cancer Hospital and Institute
Old Name:
None
Old Organization:
None